phase 2 retatrutide 🩺 in type diabetes: TRANSCEND-T2D-1 3 results → HbA1c ↓2.0% + weight ↓16.8% at 40 weeks. A triple agonist that tackles both glycemia and obesity simultaneously. 📊💊 Ref: Lilly Online—Effects of #retatrutide on #body

However, both are potent anti-oxidants and participate in reducing oxidative stress in the body

Los tratamientos incisivos que utilizan mquinas y medicamentos tienen como objetivo fundamental reducir la grasa al daar las clulas grasas y promover el metabolismo, en lugar de eliminar la grasa directamente

What SKOR does well

Hyman SE (2003)

Therapeutic targeting of ferroptosis holds great promise for mitigating ARDS severity

Studies show that patients taking GLP-1 medications often experience systolic and diastolic blood pressure improvements alongside weight loss, suggesting a connection between the medication class and heart health outcomes